These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Does the piperacillin minimum inhibitory concentration for Pseudomonas aeruginosa influence clinical outcomes of children with pseudomonal bacteremia? Tamma PD; Turnbull AE; Milstone AM; Hsu AJ; Carroll KC; Cosgrove SE Clin Infect Dis; 2012 Sep; 55(6):799-806. PubMed ID: 22696019 [TBL] [Abstract][Full Text] [Related]
7. [Bacterial meningitis and Pseudomonas aeruginosa: apropos of a case]. Batlle Almodóvar Mdel C; Dickinson F; Pérez Monrás M; Tamargo Martínez I; Similis A Rev Cubana Med Trop; 2005; 57(3):230-2. PubMed ID: 17969281 [TBL] [Abstract][Full Text] [Related]
8. A Curious Case of Actinomyces Naeslundii Bacteremia in a Patient with Metastatic Pancreatic Cancer. De Keyser R; Ram A; Dasanu CA Conn Med; 2016 Sep; 80(7):417-418. PubMed ID: 29782130 [TBL] [Abstract][Full Text] [Related]
13. Development of a combination antibiogram for Pseudomonas aeruginosa bacteremia in an oncology population. Smith ZR; Tajchman SK; Dee BM; Bruno JJ; Qiao W; Tverdek FP J Oncol Pharm Pract; 2016 Jun; 22(3):409-15. PubMed ID: 25956419 [TBL] [Abstract][Full Text] [Related]
14. Orbital cellulitis and endophthalmitis in pseudomonas septicemia. Luemsamran P; Pornpanich K; Vangveeravong S; Mekanandha P Orbit; 2008; 27(6):455-7. PubMed ID: 19085303 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for the failure of treatment of Yoshida S; Suzuki K; Suzuki A; Okada H; Niwa T; Kobayashi R; Murakami N; Ogura S; Itoh Y Pharmazie; 2017 Jul; 72(7):428-432. PubMed ID: 29441942 [TBL] [Abstract][Full Text] [Related]
16. Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study. Su TY; Ye JJ; Yang CC; Huang CT; Chia JH; Lee MH Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):52. PubMed ID: 28738848 [TBL] [Abstract][Full Text] [Related]
17. Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia. Paul M; Leibovici L Lancet Infect Dis; 2005 Apr; 5(4):192-3; discussion 193-4. PubMed ID: 15792730 [No Abstract] [Full Text] [Related]
18. Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection. Joo EJ; Kang CI; Ha YE; Park SY; Kang SJ; Wi YM; Lee NY; Chung DR; Peck KR; Song JH Infection; 2011 Aug; 39(4):309-18. PubMed ID: 21594653 [TBL] [Abstract][Full Text] [Related]
20. Time-to-positivity of blood culture: An independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia. Tang PC; Lee CC; Li CW; Li MC; Ko WC; Lee NY J Microbiol Immunol Infect; 2017 Aug; 50(4):486-493. PubMed ID: 26455486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]